Need a specific person's email?
Browse Skye Bioscience Inc.'s employee directory (about 17 employees) and reveal verified emails free.
Skye Bioscience Inc.'s most common email format is FL@skyebioscience.com (ex. JD@skyebioscience.com), used for 71% of skyebioscience.com addresses. Skye Bioscience Inc. uses 3 email patterns.
| Format | Example | Share of skyebioscience.com |
|---|---|---|
| FL@skyebioscience.comMost common | JD@skyebioscience.com | |
| FLast@skyebioscience.com | JDoe@skyebioscience.com | |
| LF@skyebioscience.com | DJ@skyebioscience.com |
Browse Skye Bioscience Inc.'s employee directory (about 17 employees) and reveal verified emails free.
Biotechnology ResearchCalifornia, United States11-50 Employees
Skye Bioscience Inc. is a biotechnology research company focused on metabolic health, developing new molecules that modulate G-protein coupled receptors. The firm aims to deliver first-in-class therapies with distinct clinical and potential commercial advantages by pursuing biologic targets supported by human proof of mechanism. Based in San Diego, California, the company operates with a relatively small to mid-sized team and concentrates on obesity and related metabolic disorders. Its lead candidate nimacimab is a peripherally restricted antibody that inhibits CB1, and the company planned to initiate a Phase 2 trial in obesity in the third quarter of 2024, comparing monotherapy with a combination approach involving Wegovy, a GLP-1 receptor agonist. In January 2026 Skye announced a collaboration with Halozyme Therapeutics to explore higher-dose subcutaneous administration strategies for nimacimab.
Most common format
FL@skyebioscience.com
Example: JD@skyebioscience.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.